Read the press release at WisBusinessExact Sciences: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

Wisconsin State Journal: Exact Sciences says its next cancer test could begin studies in 2018

Xconomy: Exact Sciences Again Boosts Sales Projections for Flagship Product